Clinical Trial Update: Safety and Immunogenicity of an HIV Vaccine in Normal Adult Volunteers [Phase 1]

View source ↗

Summary

Phase 1 clinical trial reports safety and immunogenicity data for an HIV vaccine in healthy adults, indicating tolerability and immune response in this early-st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• HIV vaccine

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Healthy, HIV Infections | Phase 1 | Status: COMPLETED